DFTX logo
DFTX NASDAQ US

Definium Therapeutics, Inc. - Common Shares

Website · IPO May 2015
$20.68
▲ +$0.08 (+0.39%)
Vol 2.0M

Wall Street Consensus

20 analysts · Apr 2026
7
Strong Buy
12
Buy
1
Hold
0
Sell
0
Strong Sell
95.0%
Buy Rating

Price Chart

Earnings

Beat rate: 25.0%
Next Report May 06, 2026
EPS Estimate: $-0.49
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.49
Dec 2025 $-0.50 $-0.50 $0.00
Sep 2025 $-0.51 $-0.78 $-0.27
Jun 2025 $-0.37 $-0.50 $-0.13

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Revenue
Net Income -$34.7M -$23.3M -$42.7M -$67.3M -$50.4M

Financial Health

Free Cash Flow
-$43.0M
Net Debt
-$217.3M
Cash
$257.8M
Total Debt
$40.6M
As of Dec 31, 2025

Peer Comparison

Ticker Mkt Cap P/E P/S ROE Margin Beta
DFTX
ELVN $913.9M -24.9% 0.27
PAHC $1.5B 22.4 1.1 24.4% 4.9% 0.79
NKTR $860.0M 13.7 -139.4% -184.9% 1.29
OCUL $2.6B 46.4 -87.2% -447.6% 0.89
INVA $1.5B 11.7 3.8 16.6% 32.8% 0.44
ANIP $1.8B 43.7 2.1 8.8% 4.9% 0.50

Latest News

No related news yet